scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF02427521 |
P953 | full work available at URL | http://link.springer.com/article/10.1007/BF02427521/fulltext.html |
http://link.springer.com/content/pdf/10.1007/BF02427521 | ||
http://link.springer.com/content/pdf/10.1007/BF02427521.pdf | ||
P698 | PubMed publication ID | 485455 |
P2093 | author name string | R. Fahlbusch | |
H. K. Rjosk | |||
K. von Werder | |||
P2860 | cites work | gynaecologist | Q2640827 |
Transient Bitemporal Hemianopsia During Pregnancy After Treatment of Galactorrhea-Amenorrhea Syndrome with Bromocriptine | Q28330320 | ||
Outcome of pregnancy in mothers given bromocriptine | Q34516329 | ||
Hypothalamic-pituitary function in diverse hyperprolactinemic states | Q34518805 | ||
Visual failure from pituitary and parasellar tumours occurring with favourable outcome in pregnant women | Q37038474 | ||
A radioimmunoassay for human prolactin | Q37483989 | ||
Impaired LH Release Following Exogenous Estrogen Administration in Patients with Amenorrhea-Galactorrhea Syndrome | Q39985106 | ||
Effect of Prolactin on LH Receptor in Rat Luteal Cells | Q39994906 | ||
Hyperprolactinemia. Pathophysiology, clinical significance, therapy | Q40838472 | ||
Functional Delineation of Hyperprolactinemic-Amenorrhea1 | Q41271348 | ||
Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptine (CB 154) clinical response and pattern of pituitary and steroid hormones before and during therapy | Q42448322 | ||
Suppression of prolactin secretion by L-dopa in the stalk-sectioned rhesus monkey | Q43968741 | ||
Pregnancy in patients with pituitary tumors | Q44441829 | ||
Acute visual loss during pregnancy after bromocriptine-induced ovulation. The elusive tumor | Q44524885 | ||
Prolactin oversuppression | Q45073956 | ||
Clinical and hormonal response to bromocriptin (CB-154) in the galactorrhea syndromes | Q45264139 | ||
Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154) | Q46014285 | ||
Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumours | Q48196801 | ||
Hyperprolactinemic anovulatory syndrome | Q48421284 | ||
Long-term Treatment of Galactorrhoea and Hypogonadism with Bromocriptine | Q48555334 | ||
Human prolactin, its isolation, assay and clinical applications | Q48746386 | ||
Human prolactin: Isolation and some properties | Q51121611 | ||
Sarcoma: a possible late result of effective radiation therapy for pituitary adenoma. Report of two cases. | Q51235748 | ||
BRAIN NECROSIS AFTER IRRADIATION OF THE HYPOPHYSIS IN CUSHING'S DISEASE. | Q51274026 | ||
Prolactin secretion in patients treated with various drugs: phenothiazines, tricyclic antidepressants, reserpine, and methyldopa. | Q54271753 | ||
Visual complications following irradiation for pituitary adenomas and craniopharyngiomas | Q54545603 | ||
Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine | Q54659259 | ||
An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea | Q55003808 | ||
Visual disturbance in pregnancy after induction of ovulation | Q55153394 | ||
Emergency hypophysectomy in pregnancy after induction of ovulation | Q55288900 | ||
Prolactin response to thyrotropin releasing hormone in normal subjects | Q67240118 | ||
Prolactin secretion in sixty-five patients with galactorrhea | Q67268702 | ||
Induction of ovulation in infertile women with pituitary tumors | Q67284605 | ||
Pregnancy, prolactin, and pituitary tumours | Q67322958 | ||
Serum prolactin levels in untreated primary hypothyroldism | Q67323590 | ||
Bromocriptine treatment of female infertility: report of 13 pregnancies | Q67352733 | ||
Treatment of patients with prolactinomas | Q67459568 | ||
Conservative management of a pituitary tumor during pregnancy following induction of ovulation with gonadotropins | Q67541232 | ||
Management of hyperprolactinaemic amenorrhoea | Q67583331 | ||
Human pituitary prolactin (hPRL): the entire linear amino acid sequence | Q67715265 | ||
Ovarian response to exogenous gonadotropins in women with elevated serum prolactin | Q67760056 | ||
Hyperprolactinemic amenorrhea. Clinical relevance, endocrine features, therapy (author's transl) | Q67852906 | ||
The influence of the prolactin inhibitor bromocriptin (CB 154) on human luteal function in vivo | Q67861411 | ||
Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine | Q68298439 | ||
Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): Restoration of ovulatory function and fertility | Q69557619 | ||
Advances in the treatment of the galactorrhoea-amenorrhoea-syndrome: Induction of ovulation and inhibition of lactation with 2-Br-alpha-ergo-cryptine (author's transl) | Q69742621 | ||
Prolactin-secreting pituitary microadenomas: roentgenologic diagnosis | Q69818026 | ||
P433 | issue | 1-4 | |
P407 | language of work or name | German | Q188 |
P304 | page(s) | 518-530 | |
P577 | publication date | 1979-07-01 | |
1979-07-20 | |||
P1433 | published in | Archives of gynecology | Q27709107 |
P478 | volume | 228 |